资讯
1 天
News-Medical.Net on MSNManipulating a master regulator prevents tumor growth in miceA protein identified nearly 40 years ago for its ability to stimulate the production of red blood cells plays a surprising, ...
Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.
Cold” tumors are resistant to common immunotherapies. Stanford Medicine researchers have uncovered a master regulator that ...
3 天on MSN
Glioblastoma multiforme is an aggressive brain tumor that mainly affects adults. Approximately 30,000 people in the U.S. are ...
Non-alcoholic fatty liver disease (NAFLD) is a hepatic metabolic syndrome resulting from lipid metabolic imbalance.
The liver breaks down dietary fructose into lipids that are used by cancer ... Tumors in mice exposed to fructose grew faster compared to those in mice on a sugar-free diet. To understand how fructose ...
The global humanized liver mice model market is on a strong growth trajectory, fueled by the increasing prevalence of liver diseases and significant technological advancements in genetic engineering.
“What blew my mind is that when we implant these tissues into a mouse with liver injury, the tissue seeds just blossom,” says study author Kelly Stevens, who conducted the experiments as a postdoc in ...
Male sex and benign liver tumor: an a priori suspicious combination. The major risk of a benign liver tumor is … that it is not benign. Benign does not always mean without risk. To reassure a ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果